Discover why Altria is still a buy: 6.8% dividend, discounted valuation, FDA-approved nicotine pouches, and $85.40 bull ...
Traders went risk off.
Despite offering high dividend returns at a low price, missteps and revenue declines may dampen the appeal of Altria stock.
Altria Group, Inc. expects continued growth in adjusted diluted EPS and in dividends until 2028. Click here to read why MO ...
Both of these stocks are considered Dividend Kings.
So, should you buy or sell Altria stock after the recent decline? Before addressing this, if you are looking for an upside ...
Altria has outperformed the broader market over the past year, but analysts are cautious about the stock’s prospects.
MarketBeat on MSN
Is Altria becoming more than an income stock?
Altria Group, Inc. (NYSE: MO) stock is off to a strong start in 2026, up more than 7.3%. However, MO stock was down nearly 3% ...
MO and PM ramp up smoke-free growth, using pricing power and innovation to counter falling cigarette demand and reshape ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results